Cargando…

Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment

Treatment of eosinophilic gastroenteritis (EGE) is mainly empirical and is based on the assessment of symptom severity and the experience of clinicians. Patients with mild disease can be treated symptomatically, while patients with more severe symptoms or malabsorption symptoms require more aggressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuźmiński, Andrzej, Rosada, Tomasz, Przybyszewska, Justyna, Ukleja-Sokołowska, Natalia, Bartuzi, Zbigniew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395056/
https://www.ncbi.nlm.nih.gov/pubmed/37538288
http://dx.doi.org/10.5114/pg.2022.118635
_version_ 1785083507800801280
author Kuźmiński, Andrzej
Rosada, Tomasz
Przybyszewska, Justyna
Ukleja-Sokołowska, Natalia
Bartuzi, Zbigniew
author_facet Kuźmiński, Andrzej
Rosada, Tomasz
Przybyszewska, Justyna
Ukleja-Sokołowska, Natalia
Bartuzi, Zbigniew
author_sort Kuźmiński, Andrzej
collection PubMed
description Treatment of eosinophilic gastroenteritis (EGE) is mainly empirical and is based on the assessment of symptom severity and the experience of clinicians. Patients with mild disease can be treated symptomatically, while patients with more severe symptoms or malabsorption symptoms require more aggressive therapy. So far, several therapeutic options have been proposed, including the following: dietary treatment, glucocorticosteroids, inhibitors of leukotriene receptors, mast cell stabilizers, immunomodulating drugs, and biological drugs. Unfortunately, there is still a lack of well-designed, prospective. and randomized clinical trials involving large groups of patients with EGE and assessing the effectiveness of individual treatments. More research is needed to compare the efficacy and safety profiles of the various treatments available, and to select the prognostic factors of relapse, which in turn will be extremely important in making decisions about the initial treatment phase and maintenance therapy.
format Online
Article
Text
id pubmed-10395056
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-103950562023-08-03 Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment Kuźmiński, Andrzej Rosada, Tomasz Przybyszewska, Justyna Ukleja-Sokołowska, Natalia Bartuzi, Zbigniew Prz Gastroenterol Review Paper Treatment of eosinophilic gastroenteritis (EGE) is mainly empirical and is based on the assessment of symptom severity and the experience of clinicians. Patients with mild disease can be treated symptomatically, while patients with more severe symptoms or malabsorption symptoms require more aggressive therapy. So far, several therapeutic options have been proposed, including the following: dietary treatment, glucocorticosteroids, inhibitors of leukotriene receptors, mast cell stabilizers, immunomodulating drugs, and biological drugs. Unfortunately, there is still a lack of well-designed, prospective. and randomized clinical trials involving large groups of patients with EGE and assessing the effectiveness of individual treatments. More research is needed to compare the efficacy and safety profiles of the various treatments available, and to select the prognostic factors of relapse, which in turn will be extremely important in making decisions about the initial treatment phase and maintenance therapy. Termedia Publishing House 2022-08-09 2023 /pmc/articles/PMC10395056/ /pubmed/37538288 http://dx.doi.org/10.5114/pg.2022.118635 Text en Copyright © 2023 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) )
spellingShingle Review Paper
Kuźmiński, Andrzej
Rosada, Tomasz
Przybyszewska, Justyna
Ukleja-Sokołowska, Natalia
Bartuzi, Zbigniew
Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment
title Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment
title_full Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment
title_fullStr Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment
title_full_unstemmed Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment
title_short Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment
title_sort eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? part 2. treatment
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395056/
https://www.ncbi.nlm.nih.gov/pubmed/37538288
http://dx.doi.org/10.5114/pg.2022.118635
work_keys_str_mv AT kuzminskiandrzej eosinophilicgastroenteritisamanifestationofanallergicdiseaseinthegastrointestinaltractpart2treatment
AT rosadatomasz eosinophilicgastroenteritisamanifestationofanallergicdiseaseinthegastrointestinaltractpart2treatment
AT przybyszewskajustyna eosinophilicgastroenteritisamanifestationofanallergicdiseaseinthegastrointestinaltractpart2treatment
AT uklejasokołowskanatalia eosinophilicgastroenteritisamanifestationofanallergicdiseaseinthegastrointestinaltractpart2treatment
AT bartuzizbigniew eosinophilicgastroenteritisamanifestationofanallergicdiseaseinthegastrointestinaltractpart2treatment